Targovax ASA: Invitation to fourth quarter and full year 2016 results presentation Thursday 16 February
Oslo, Norway, 6 February 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, will announce its fourth quarter and full year 2016 results on Thursday, 16 February 2017. A …